Latest filing published 11 May 2023 for Acadia Healthcare Company, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Christopher L. Howard in Acadia Healthcare Company, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 5 February 2016 to 9 May 2023, the count stands at 12 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 11 May 2023 came the latest disclosure, a share grant in Acadia Healthcare Company, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations